Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Respondents may be grasping
"The move defends the investments of the enormous MMP Portfolio licensee community of nearly 100 global industry leaders (with combined annual revenue of approximately $1.4 trillion), the investments of PTSC and TPL in the MMP Portfolio Licensing Program, and the investments of TPL in its own semiconductor product lines." <<<<>>>>. The above is from an Alliacense announcement last year about filing at the ITC and NDoC. If you think the MMP will get another 1.4 trillion from the remaining infringets, multiply that by the NDoC award of .000125 you get 175 million probably divided by 3 for the Leckrone Family and Moore, Ottesson, and PTSC. That equals 55 million for PTSC for the remainder of the MMP. Who has Alliacense notified? Commingling might also continue? So, again I ask, what is the trigger point where PTSC would act? If PTSC forecasts after a possible ITC loss that they are set to make 55 million or less for the remainder of the MMP life, then one would think everyone would be on the same page for PTSC to act. The numbers above could change and please post your own if you want. I'm hopeful they could average 2 million from the remaining companies. How many companies remain? 300 plus? I hope so and hopefully this post is a worst case scenario and PTSC has a plan for it.
Share
New Message
Please login to post a reply